Business as usual for Indian exports under EU falsified meds directive
This article was originally published in Scrip
Executive Summary
Five months since the introduction of the new EU requirement of certification of the good manufacturing practice (GMP) standards of imported active pharmaceutical ingredients (APIs), India has issued more than 250 written confirmations of such compliance, and domestic exporters, in general, suggest that it's been "business as usual" with no major hiccups along the way.